Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, dated November 5, 2020, reports on the Combined Ordinary and Extraordinary General Meeting of Cellectis S.A. held on November 4, 2020. The filing serves to disclose the voting results of this shareholder meeting.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural report regarding corporate governance and does not contain financial statements or performance metrics.
Material Changes
No material financial changes versus the prior comparable period are disclosed in this filing. The document focuses solely on the administrative outcome of the shareholder meeting.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The primary content is the attachment of voting results (Exhibit 99.1) for the meeting held on November 4, 2020.
Key Facts for Investors
- The company held a Combined Ordinary and Extraordinary General Meeting on November 4, 2020.
- Voting results for the meeting are attached as Exhibit 99.1 to this filing.
- This report does not include financial performance data or forward-looking guidance.
- The filing was signed by André Choulika, Chief Executive Officer, on November 5, 2020.